5h
Zacks.com on MSNBPMC Q4 Earnings and Sales Miss Estimates, Shares DeclineBlueprint Medicines Corporation BPMC reported fourth-quarter 2024 adjusted loss of 79 cents per share, wider than the Zacks ...
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...
20h
The Healthy on MSNOTC Medication Mistakes: Doctors Advise You To Avoid Doing TheseJust because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...
Pharmaceutical Lipids Market to Reach USD 9,036.5 Million by 2035, Rising demand for lipid-based drug delivery fuels market growth, enhancing solubility, stability, and bioavailability of APIs.NEWARK, ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...
Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
Higher PPI dosages improve outcomes in those with gastroesophageal disease, but it is unclear whether twice-daily dosing is more effective.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results